In conclusion, our study described expression and function of TRPV4 (and KCa3.1) channels in melanoma cells and revealed a potential utility of TRPV4-activators as alternative or adjuvant therapeutic strategy to produce melanoma cell death and to impede tumor progression. Here, KCNN4 is linked to melanoma.